ArticleBlood2017

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.

Steven Goossens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.